Sign In
Markets
Concord Biotech shares up over 27% in debut rally
Concord Biotech IPO subscribed 24.86 times on closing day
Concord Biotech IPO subscribed two-times on Day 2
Rakesh Jhunjhunwala-backed Concord Biotech files draft papers to float IPO
